AstraZeneca to discontinue late-stage lung cancer trial for volrustomig 17-Aug 14:41

AstraZeneca on Monday said it is discontinuing ​a late stage trial ‌that tested volrustomig plus chemotherapy in patients with metastatic non-small cell ​lung cancer.

Take Five: The heat is on 17-Aug 14:41

World markets are in full summer mode, even as tensions flare in the Gulf and there is no shortage of risk events for investors, including a health check on the mighty U.S. consumer and enough focus on inflation to bring gold back into the spotlight.

Alibaba to sell Lingxi Games in more than $2 billion deal, source says 17-Aug 14:41

Alibaba Group is expected to reap more ‌than $2 billion from the sale of its game developer unit Lingxi Games to private equity firm Trustar Capital, a person familiar with the matter told Reuters.